We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Assurant
AIZ
$13.6B
| $18.1M | 0.32% |
179,325
-25,591
| -12% | -$2.53M |
|
102
Idexx Laboratories
IDXX
$42.5B
| $18.1M | 0.32% |
115,552
+670
| +0.6% | +$105K |
|
103
Eli Lilly
LLY
$1.06T
| $18M | 0.32% |
212,939
+109,620
| +106% | +$9.33M |
|
|
TWTR
104
DELISTED
Twitter, Inc.
TWTR
| $17.7M | 0.31% |
737,299
+18,300
| +3% | +$376K |
|
105
Palo Alto Networks
PANW
$265B
| $17.7M | 0.31% |
731,460
+601,320
| +462% | +$14.6M |
|
106
Align Technology
ALGN
$12B
| $17.5M | 0.31% |
78,611
-9,055
| -10% | -$2.06M |
|
107
M&T Bank
MTB
$35.6B
| $17.4M | 0.31% |
101,636
+2,317
| +2% | +$384K |
|
|
WBC
108
DELISTED
WABCO HOLDINGS INC.
WBC
| $17.3M | 0.3% |
120,638
+49,764
| +70% | +$7.31M |
|
109
Molina Healthcare
MOH
$10.5B
| $17.3M | 0.3% |
225,480
+138,420
| +159% | +$9.99M |
|
|
AAN.A
110
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $17.3M | 0.3% |
433,380
-66,197
| -13% | -$2.64M |
|
111
F5
FFIV
$21.9B
| $17.2M | 0.3% |
131,141
+6,110
| +5% | +$759K |
|
|
112
Yum China
YUMC
$14.8B
| $17.1M | 0.3% |
+427,927
| New | +$17.6M |
|
|
CTXS
113
DELISTED
Citrix Systems Inc
CTXS
| $17M | 0.3% |
193,269
+1,860
| +1% | +$158K |
|
114
Hewlett Packard
HPE
$63.1B
| $16.9M | 0.3% |
1,180,216
+70,100
| +6% | +$996K |
|
115
NiSource
NI
$22.4B
| $16.8M | 0.3% |
654,390
-11,520
| -2% | -$306K |
|
116
Brunswick
BC
$5.17B
| $16.8M | 0.29% |
303,885
+47,060
| +18% | +$2.56M |
|
117
Cooper-Standard Automotive
CPS
$519M
| $16.7M | 0.29% |
136,276
+15,205
| +13% | +$1.79M |
|
118
Owens Corning
OC
$11.2B
| $16.4M | 0.29% |
178,356
+990
| +0.6% | +$83.4K |
|
119
Ciena
CIEN
$57.7B
| $16.3M | 0.29% |
777,765
+314,677
| +68% | +$6.67M |
|
120
Zebra Technologies
ZBRA
$12.2B
| $16.1M | 0.28% |
154,783
+32,612
| +27% | +$3.55M |
|
|
PARA
121
DELISTED
Paramount Global Class B
PARA
| $15.9M | 0.28% |
269,471
-943
| -0.3% | -$54.2K |
|
122
Lincoln Electric
LECO
$13.7B
| $15.9M | 0.28% |
173,314
+112,864
| +187% | +$10.3M |
|
123
NewMarket
NEU
$7.08B
| $15.6M | 0.27% |
39,141
-1,168
| -3% | -$473K |
|
124
Insperity
NSP
$1.83B
| $15.5M | 0.27% |
270,123
+28,173
| +12% | +$1.49M |
|
125
Dell
DELL
$284B
| $15.4M | 0.27% |
676,484
+546,034
| +419% | +$12.4M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.